Netflix’s AI Doc, in 5 Minutes | Edition 340
Who’s in Netflix’s The AI Doc, what they warn about, and whether 104 minutes is worth your night.
If you’ve felt both “AI will cure cancer” and “AI will end us” in the same week, there’s now a movie about exactly that feeling. It’s called The AI Doc: Or How I Became an Apocaloptimist, and it landed on Netflix in the US on September 15, 2026, for a 10-month run.
Most people won’t sit down for 104 minutes on AI risk. So here’s the whole thing in five: who made it, who’s in it, the five arguments it walks you through, what critics thought, and whether it’s worth your night.
Who made it, and why
Daniel Roher won the Oscar for Navalny. Then his wife, filmmaker Caroline Lindy, got pregnant with their first child, and Roher started losing sleep over the world his son would inherit. So he did what documentary filmmakers do: he went and asked.
He co-directed with Charlie Tyrell. Daniel Kwan — one half of the duo behind Everything Everywhere All at Once — is a producer. The film premiered at Sundance on January 27, 2026, opened in US theaters through Focus Features on March 27, and made about $1.3 million at the box office before moving to streaming. Its Netflix arrival is part of Universal’s deal that sends Focus Features films to Netflix after an initial Peacock window.
Who’s in it
The headline is access. Roher sat down with three of the five people running America’s biggest AI labs: OpenAI’s Sam Altman, Anthropic’s Dario Amodei (along with his sister and co-founder, Daniela Amodei), and Google DeepMind’s Demis Hassabis. Meta’s Mark Zuckerberg declined, and Elon Musk didn’t end up sitting down.
Around them is most of the AI-risk debate in one room: Tristan Harris and Aza Raskin of the Center for Humane Technology, historian Yuval Noah Harari, University of Washington linguist Emily Bender, AI researcher Deborah Raji, futurist Peter Diamandis, RAND CEO Jason Matheny, Ilya Sutskever, and the field’s best-known pessimist, Eliezer Yudkowsky.
The five big ideas
1. The doom case. The film opens with the pessimists, and it doesn’t soften them. When Roher asks Yudkowsky whether AI could cause humanity’s collapse, Yudkowsky corrects the word: not collapse, extermination — and an abrupt one. His outlook is grim enough that he advises against bringing more children into the world, which lands hard in a film built around a pregnancy.
2. The boom case. Just when it gets too dark, the film flips to the optimists. Diamandis makes the case that AI will hand ordinary people abilities that were unimaginable a generation ago: faster science, cheaper medicine, abundance.
3. The builders. The CEO interviews are the reason to watch. Reviewers across the board noted how candid Altman and Amodei are about the risk of the technology running away from its makers. Amodei’s image for the race is a train: you can’t step in front of it and stop it, and anyone who tries just gets flattened. The question he leaves hanging is who is steering.
4. You don’t get one without the other. Tristan Harris is the film’s spine. After the doom and the boom, he walks Roher to the uncomfortable middle: the same technology delivers the cures and the danger. You don’t get to order the upside à la carte. So the real question is how good the good has to be to justify the bad.
5. The middle path. The word “apocaloptimist” comes from RAND’s Jason Matheny: someone who takes the worst case seriously and still works toward the best one. By the end, Roher claims it for himself — which is where the title comes from.
What critics say
It sits in the high 80s on Rotten Tomatoes. Variety called it scary, dizzying and essential. The Hollywood Reporter noted a hyper, never-slow-down pace that mostly works. Lawrence Lessig called Roher’s pick of subject the most important question facing humanity.
The knocks are worth knowing before you press play. The Globe and Mail found its look at the environmental cost of AI data centers too brief. Variety felt the ending tilts too far toward optimism — on purpose. And AP’s reviewer doubted it would turn many viewers into apocaloptimists, comparing it to Dr. Strangelove — the film its subtitle nods to — which didn’t exactly make anyone warm to the bomb.
Should you watch it?
If you read this newsletter, you know most of the arguments. Watch it anyway for two reasons. First, the CEOs answering hard questions on camera, in their own words, is rare and worth seeing. Second, it’s the best single thing to hand the family member who keeps asking you whether they should be worried — it takes their fear seriously without feeding it.
Where to watch: Netflix in the US since September 15. It’s also available to rent or buy on other major platforms. The official trailer is on Focus Features’ YouTube channel →
| Claim | Source | What it doesn’t prove |
|---|---|---|
| On Netflix US from Sept 15, 2026, for a 10-month window | What’s on Netflix, Aug 18, 2026 | Availability outside the US |
| Directed by Daniel Roher and Charlie Tyrell; Sundance Jan 27, theaters Mar 27, 104 minutes | Wikipedia, citing Focus Features and trade press | Anything about quality |
| Altman, Amodei and Hassabis interviewed; Zuckerberg and Musk did not appear | AP, Fox News, KQED reviews, Mar 2026 | How much of each interview made the final cut |
| “Apocaloptimist” was coined by RAND’s Jason Matheny | Film Festival Today (SXSW review); Variety says an interview subject coined it | That Matheny invented the word outside the film |
| High-80s Rotten Tomatoes score | Rotten Tomatoes, snapshot Sept 2026 | Audience reaction; scores move as reviews are added |
The one-liner
The AI Doc doesn’t tell you what to think about AI. It shows you the people deciding what happens next, and lets you judge how comfortable you are with them doing it.
Disclosure: AI Super Simplified is built with Claude, made by Anthropic — whose CEO appears in the film. We have no relationship with the filmmakers, Focus Features or Netflix.